GSMA
18.9.2018 12:43:07 CEST | Business Wire | Press release
Europe’s mobile ecosystem is forecast to account for more than 4 per cent of the region’s GDP by 2022, but the right regulatory action must be taken to position Europe as a global 5G leader and establish a genuine EU Digital Single Market, according to a new report published by the GSMA today. The latest regional edition of the GSMA’s flagship Mobile Economy series was released today at the GSMA Mobile 360 – Europe conference, where senior representatives from the mobile industry and regulatory bodies are convening to debate the future of telecoms in Europe.
“5G networks in Europe are expected to provide coverage to almost three-quarters of the region’s population by 2025 and Europe is set to become the world’s third-largest 5G market behind Asia Pacific and North America by this point,” commented Mats Granryd, Director General of the GSMA. “However, success in the 5G era will rest on the ability of governments to implement forward-looking regulatory frameworks that encourage sustainable investment, drive innovation and protect consumers.”
Mobile a Driver of Economic Growth in Europe
In 2017, mobile technologies and services generated 3.3 per cent of GDP1 in Europe, a contribution that amounted to EUR550 billion of economic value added. This contribution is expected to increase to EUR720 billion (4.1 per cent of GDP) by 2022. Europe’s mobile ecosystem also supported 2.5 million jobs in the region in 2017 and made a public funding contribution of EUR100 billion – mainly in the form of general taxation, including VAT, corporate taxes and employment taxes.
Reforms to Drive Digital Evolution
For Europe to realise the full potential of 5G, it needs to create a more supportive policy environment that positions it as a preferred location for investment. Regulation should seek to:
- Encourage a strong pro-investment environment that will allow the mobile industry to make investments that will ultimately benefit consumers;
- Support a policy of ‘same service, same rules’ that would lead to more competition, innovation and higher consumer welfare;
- Provide timely access to harmonised spectrum in the right frequencies, at the right time, and under the right long-term conditions for operators to invest in future networks and services; and
- Enable European operators to harness the full potential of data to innovate and compete globally while protecting the privacy and confidentiality of consumers
Europe Prepares to Move to 5G
Europe is the most highly penetrated regional mobile market in the world. According to today’s report, there were 465 million unique mobile subscribers2 in Europe at the end of 2017, representing 85 per cent of the population. This is forecast to grow to 481 million – 88 per cent of the population – by 2025.
Although there is still headroom for 4G growth in many markets, the first 5G launches by European mobile operators are anticipated by the end of the decade. By 2025, it is forecast that 5G will account for around 200 million connections, corresponding to a 29 per cent share of total connections in Europe.3
“Momentum is now building in Europe as we enter the 5G era, as mobile operators conduct trials and prepare to ramp up 5G investments over the coming years,” added Granryd. “Meanwhile, in light of ongoing financial and competitive pressures, Europe’s operators are looking beyond their core telco business in order to explore and unlock new revenue streams in both consumer and enterprise markets across a range of verticals.”
The new report ‘The Mobile Economy: Europe 2018’ is authored by GSMA Intelligence, the research arm of the GSMA. To access the full report and related infographics, please visit: www.gsma.com/mobileeconomy/europe/
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
1 GDP contribution includes direct mobile ecosystem contribution (0.9%); indirect contribution (0.5%); and productivity improvements (1.9%)
2 A unique mobile subscriber represents an individual that can account for multiple SIM connections
3 Excluding licenced cellular IoT connections
View source version on businesswire.com: https://www.businesswire.com/news/home/20180918005468/en/
Contact:
For the GSMA Beau Bass +44 79 7662 4962 beau.bass@webershandwick.com or Olivier Lechien +32 479 99 01 63 olechien@gsma.com or GSMA Press Office pressoffice@gsma.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
